Kathleen D. Scott Dermata Therapeutics, Inc. (DRMA) insider trading activity

DRMA Quotes by TradingView

Kathleen D. Scott is of Dermata Therapeutics, Inc.. Currently has a direct ownership of 27,145 shares of DRMA, which is worth approximately $64,876. The most recent transaction as insider was on Oct 06, 2022, when has been sold 11,359 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.1K
0% 3M change
0% 12M change
Total Value Held $64,876

Kathleen D. Scott Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2022
BUY
Grant, award, or other acquisition
-
11,359 Added 29.5%
27,145 Common Stock
Jul 07 2022
BUY
Grant, award, or other acquisition
-
9,960 Added 38.69%
15,786 Common Stock
Apr 07 2022
BUY
Grant, award, or other acquisition
-
5,826 Added 50.0%
5,826 Common Stock

Also insider at

SBTX
Silverback Therapeutics, Inc. Healthcare
Chief Financial Officer
GFOR-WT
Graf Acquisition Corp. IV
Director
KDS

Kathleen D. Scott

San Diego, CA

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DRMA